Detalhe da pesquisa
1.
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood
; 140(5): 504-515, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512184
2.
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study.
Haematologica
; 109(1): 209-219, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439343
3.
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Blood
; 137(23): 3272-3276, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534891
4.
Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory sézary syndrome.
Invest New Drugs
; 41(2): 350-355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004644
5.
DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
Haematologica
; 108(6): 1604-1615, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453104
6.
From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.
Ann Diagn Pathol
; 62: 152077, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549077
7.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074072
8.
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Ann Hematol
; 101(2): 335-340, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668982
9.
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
Mod Pathol
; 34(12): 2154-2167, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226673
10.
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Ann Hematol
; 100(3): 667-673, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439304
11.
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma.
Mod Pathol
; 33(3): 324-333, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383967
12.
Newer insights on how to TEC down T-ALL.
Blood
; 141(5): 444-445, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729545
13.
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Am J Hematol
; 95(6): 623-629, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239765
14.
Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].
Mod Pathol
; 36(12): 100355, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948938
15.
Safety of CAR T-cell therapy in kidney transplant recipients.
Blood
; 137(18): 2558-2562, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512386
16.
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.
Haematologica
; 108(4): 1163-1167, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384251
17.
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapy.
Br J Haematol
; 193(3): e23-e26, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748943
18.
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
Oncologist
; 20(9): 1084-91, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26099743
19.
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events.
Br J Haematol
; 167(3): 366-75, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25139740
20.
Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential.
Am J Hematol
; 94(3): E82-E85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575100